Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,074 | -20,539 | -7,745 | -17,934 | -11,723 |
| Depreciation Amortization | 115 | 71 | 35 | 118 | 77 |
| Other Working Capital | -908 | 1,243 | 705 | 3,391 | 3,002 |
| Other Operating Activity | 2,199 | 1,603 | 832 | 2,353 | 1,853 |
| Operating Cash Flow | $-29,668 | $-17,623 | $-6,173 | $-12,074 | $-6,792 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -200 | -200 | -150 | -275 | -250 |
| Investing Cash Flow | $-200 | $-200 | $-150 | $-275 | $-250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 224 | 224 |
| Debt Repayment | -3 | -2 | -1 | -606 | -507 |
| Common Stock Issued | 10,463 | 8,344 | 1,154 | 20,809 | 16,625 |
| Other Financing Activity | 0 | 0 | -162 | 93,675 | 93,675 |
| Financing Cash Flow | $10,460 | $8,342 | $991 | $114,102 | $110,018 |
| Beginning Cash Position | 103,108 | 103,108 | 103,108 | 1,355 | 1,355 |
| End Cash Position | 83,700 | 93,627 | 97,777 | 103,108 | 104,331 |
| Net Cash Flow | $-19,408 | $-9,481 | $-5,331 | $101,753 | $102,976 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,668 | -17,623 | -6,173 | -12,074 | -6,792 |
| Capital Expenditure | -200 | -200 | -150 | -275 | -250 |
| Free Cash Flow | -29,868 | -17,823 | -6,323 | -12,349 | -7,042 |